Income Statement

Fundamentals - Annual Income Statement

  Year Ending Dec 2017 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Update) Year Ending Dec 2014 (Update) Year Ending Dec 2013 (Update)
Net Sales 1.67M 1.58M 1.54M 1.46M 1.41M
Revenue 1.67M 1.58M 1.54M 1.46M 1.41M
Total Revenue 1.67M 1.58M 1.54M 1.46M 1.41M
Cost of Revenue 1.15M 1.12M 1.09M 1.03M 1.01M
Cost of Revenue, Total 1.15M 1.12M 1.09M 1.03M 1.01M
Gross Profit 516.19 461.45 455.78 421.61 404.52
Selling/General/Administrative Expense 258.03 234.32 225.18 212.29 204.09
Labor & Related Expense 4.99 1.93 7.52 2.57 1.30
Selling/General/Administrative Expenses, Total 263.03 236.25 232.70 214.86 205.39
Depreciation 35.49 34.28 32.37 29.88 27.70
Amortization of Intangibles, Operating 0.14 0.36 1.13 3.19 4.69
Depreciation/Amortization 35.63 34.64 33.50 33.07 32.39
Investment Income - Operating 8.43 2.06 0.15 3.12 4.98
Interest/Investment Income - Operating 8.43 2.06 0.15 3.12 4.98
Interest Expense (Income), Net-Operating, Total 8.43 2.06 0.15 3.12 4.98
Litigation 5.19 5.26 4.97 2.14 2.15
Impairment-Assets Held for Use
Other Unusual Expense (Income)
Unusual Expense (Income) 5.19 5.26 4.97 2.14 2.15
Other Operating Expense -- --
Other, Net 90.88 4.49 -- 26.22
Other Operating Expenses, Total 90.88 4.49 -- -- 26.22
Total Operating Expense 1.55M 1.40M 1.36M 1.29M 1.28M
Operating Income 113.04 178.75 184.46 168.42 133.39
Interest Expense - Non-Operating -4.27 -3.72 -3.65 -8.19 -15.04
Interest Expense, Net Non-Operating -4.27 -3.72 -3.65 -8.19 -15.04
Interest Income, Non-Operating 0.43 0.38 0.28 0.85
Investment Income, Non-Operating 8.43 2.06 0.15 3.12 4.98
Interest/Investment Income, Non-Operating 8.86 2.44 0.43 3.12 5.83
Interest Income (Expense), Net Non-Operating -0.03
Interest Income (Expense), Net-Non-Operating, Total 4.59 -1.27 -3.22 -5.10 -9.21
Gain (Loss) on Sale of Assets -0.71 -0.42 -0.70 -0.64 -0.32
Other Non-Operating Income (Expense) 0.00 -- -0.42 0.07 -0.04
Other, Net 0.00 -- -0.42 0.07 -0.04
Net Income Before Taxes 116.92 177.05 180.13 162.75 123.83
Income Tax – Total 27.05 68.31 69.85 63.44 46.60
Income After Tax 89.87 108.74 110.27 99.32 77.23
Net Income Before Extraordinary Items 89.87 108.74 110.27 99.32 77.23
Discontinued Operations
Extraordinary Item 8.31
Total Extraordinary Items 8.31
Net Income 98.18 108.74 110.27 99.32 77.23
Income Available to Common Excluding Extraordinary Items 89.87 108.74 110.27 99.32 77.23
Income Available to Common Stocks Including Extraordinary Items 98.18 108.74 110.27 99.32 77.23
Basic Weighted Average Shares 16.06 16.38 16.87 17.17 18.20
Basic EPS Excluding Extraordinary Items 5.60 6.64 6.54 5.79 4.24
Basic EPS Including Extraordinary Items 6.11 6.64 6.54 5.79 4.24
Dilution Adjustment
Diluted Net Income 98.18 108.74 110.27 99.32 77.23
Diluted Weighted Average Shares 16.74 16.79 17.42 17.84 18.59
Diluted EPS Excluding Extraordinary Items 5.37 6.48 6.33 5.57 4.16
Diluted EPS Including Extraordinary Items 5.86 6.48 6.33 5.57 4.16
DPS - Common Stock Primary Issue 1.08 1.00 0.92 0.84 0.76
Gross Dividends - Common Stock 17.37 16.44 15.61 14.26 12.54
Litigation Charge, Supplemental 84.69 0.05 0.18 0.45 26.33
Other Unusual Expense (Income), Supplemental 0.04 0.02 0.36
Non-Recurring Items, Total 84.69 0.05 0.21 0.47 26.69
Total Special Items 90.59 5.73 5.89 3.25 29.16
Normalized Income Before Taxes 207.51 182.78 186.01 166.01 152.99
Effect of Special Items on Income Taxes 20.96 2.21 2.28 1.27 10.98
Income Taxes Excluding Impact of Special Items 48.00 70.52 72.13 64.70 57.58
Normalized Income After Taxes 159.51 112.26 113.88 101.30 95.41
Normalized Income Available to Common 159.51 112.26 113.88 101.30 95.41
Basic Normalized EPS 9.93 6.85 6.75 5.90 5.24
Diluted Normalized EPS 9.53 6.69 6.54 5.68 5.13
Amortization of Intangibles, Supplemental 0.14 0.36 1.13 3.19 4.69
Depreciation, Supplemental 35.49 34.28 32.37 29.88 27.70
Interest Expense, Supplemental 4.27 3.72 3.65 8.19 15.04
Interest Capitalized, Supplemental
Rental Expense, Supplemental 41.21 40.03 40.02 39.61 38.99
Stock-Based Compensation, Supplemental 10.49 8.33 5.45 4.80
Advertising Expense, Supplemental
Audit-Related Fees, Supplemental 2.09 2.05 1.93 1.91 1.89
Audit-Related Fees 0.14 0.14 0.13 0.13 0.13
Tax Fees, Supplemental -- -- -- --
All Other Fees Paid to Auditor, Supplemental -- -- -- --
Gross Margin 30.97 29.26 29.53 28.95 28.62
Operating Margin 6.78 11.34 11.95 11.57 9.44
Pretax Margin 7.01 11.23 11.67 11.18 8.76
Effective Tax Rate 23.13 38.58 38.78 38.98 37.63
Net Profit Margin 5.39 6.90 7.14 6.82 5.46
Normalized EBIT 211.35 186.12 189.79 174.15 167.22
Normalized EBITDA 246.97 220.75 223.29 207.22 199.61
Current Tax - Domestic 11.72 64.70 55.03 48.58 45.35
Current Tax - Foreign 0.47 0.39 0.40 0.60 0.51
Current Tax - Local 4.14 9.93 8.10 7.29 7.73
Current Tax - Total 16.33 75.02 63.53 56.46 53.59
Deferred Tax - Domestic 10.71 -6.71 6.32 6.97 -7.00
Deferred Tax - Foreign 0.01 0.01 0.00 0.01 0.01
Deferred Tax - Total 10.71 -6.71 6.33 6.98 -6.99
Income Tax - Total 27.05 68.31 69.85 63.44 46.60
Defined Contribution Expense - Domestic 22.03 14.47 11.97 13.84 14.51
Total Pension Expense 22.03 14.47 11.97 13.84 14.51
Number of Discharges 65.64M 64.69M 64.90M 63.48M 63.00M
Net Inpatient Revenues 90.47 97.58 99.44 102.88 104.97
For a more complete picture of our financial results, please review our SEC Filings

In millions of USD (except for per share items)

Copyright Thomson Reuters Corporation

All information current at time of original publication. Read complete disclaimer for details.
Copyright © 2017, Chemed Corporation. All rights reserved.
Page last modified: 04/18/05